Literature DB >> 26699690

Changes in postoperative night bispectral index of patients undergoing thoracic surgery with different types of anaesthesia management: a randomized controlled trial.

Wen-fei Tan1, Bing Guo1, Hong Ma1, Xiao-Qian Li1, Bo Fang1, Huang-Wei Lv1.   

Abstract

This study hypothesized that different types of anaesthesia management would result in similar postoperative sleep quality. In this prospective single-blind investigation, 219 patients undergoing elective thoracic surgery were randomized into three arms: general anaesthesia, as the control group (group C); general anaesthesia combined with thoracic epidural anaesthesia (TEA) (group E); and general anaesthesia combined with infusion of 1 μg/kg dexmedetomidine (group D). Plasma samples were obtained to measure the amine and inflammatory cytokine concentrations. All patients underwent assessment with the bispectral index (BIS) for sleep quality and the visual analogue scale (VAS) for pain. The primary outcomes were inflammatory cytokine [interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α)] secretion and postoperative sleep quality on the first and second postoperative nights. The secondary outcomes were amine (adrenaline and noradrenaline) secretion during the surgical period and haemodynamic stability. The postoperative BIS area under the curve was significantly lower in group E (75.7%) than in group C (87.3%) or group D (86.5%). Patients in group E had the highest BIS of sleep efficiency index (29.2%, P < 0.05) and the lowest VAS scores (3.5, P < 0.05). Group E had lower IL-6 levels than the other two groups 24 h after surgery (P < 0.05). Patients given TEA may show reduced sleep disturbances on the first night after surgery, perhaps due to better pain management and inhibition of IL-6 release.
© 2016 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  bispectral index; inflammatory cytokine; sleep

Mesh:

Substances:

Year:  2016        PMID: 26699690     DOI: 10.1111/1440-1681.12530

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  6 in total

1.  Changes in the first postoperative night bispectral index of patients after thyroidectomy with different types of primary anesthetic management: a randomized controlled trial.

Authors:  Wen-Fei Tan; Zhi-Lin Wang; Hong Ma; Feng Jin; Huang-Wei Lu
Journal:  J Clin Monit Comput       Date:  2017-01-12       Impact factor: 2.502

2.  Effects of ultrasound-guided stellate-ganglion block on sleep and regional cerebral oxygen saturation in patients undergoing breast cancer surgery: a randomized, controlled, double-blinded trial.

Authors:  Feng Jin; Xiao-Qian Li; Wen-Fei Tan; Hong Ma; Bo Fang; A-Yong Tian; Huang-Wei Lu
Journal:  J Clin Monit Comput       Date:  2017-10-17       Impact factor: 2.502

3.  Postoperative 24-h Acute Sleep Deprivation Improves Learning and Memory Through Inhibition of Tau Phosphorylation in the Hippocampal Neurons of Splenectomized Rats.

Authors:  Yu-Wei Zhang; Xiao-Qian Li; Wen-Fei Tan; Bo Fang; Hong Ma
Journal:  Nat Sci Sleep       Date:  2020-08-24

Review 4.  Measurements and status of sleep quality in patients with cancers.

Authors:  Dongying Chen; Zongyi Yin; Bo Fang
Journal:  Support Care Cancer       Date:  2017-10-23       Impact factor: 3.603

5.  Preoperative versus postoperative ultrasound-guided rectus sheath block for improving pain, sleep quality and cytokine levels in patients with open midline incisions undergoing transabdominal gynecological surgery: a randomized-controlled trial.

Authors:  Feng Jin; Zhe Li; Wen-Fei Tan; Hong Ma; Xiao-Qian Li; Huang-Wei Lu
Journal:  BMC Anesthesiol       Date:  2018-02-09       Impact factor: 2.217

Review 6.  Dexmedetomidine attenuates one-lung ventilation associated lung injury by suppressing inflammatory responses: A systematic review and meta-analysis.

Authors:  Yun-Xiao Bai; Jie-Han Zhang; Bing-Cheng Zhao; Ke-Xuan Liu; Yao-Wu Bai
Journal:  Clin Exp Pharmacol Physiol       Date:  2021-06-14       Impact factor: 2.557

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.